Metformin-associated lactic acidosis in a patient with diabetes undergoing coronary artery bypass graft surgery: a case report | ||||
| The Egyptian Journal of Cardiothoracic Anesthesia | ||||
| Volume 17, Issue 3, December 2023 PDF (499.89 K) | ||||
| DOI: 10.4103/ejca.ejca_6_23 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Lalit Jha; Neeraj Kumar; Kunal Krishna | ||||
| Abstract | ||||
| Metformin is a commonly used first-line oral hypoglycemic agent for type 2 diabetes. Metformin associated lactic acidosis (MALA) is an extremely rare event with an estimated incidence of 0.03–0.06 per 1000 patient-years and a mortality rate of up to 50%. We report successful perioperative management of a 63-year-old man who developed MALA during his postoperative period following off-pump coronary artery bypass graft (OPCABG) surgery. MALA is a rare complication associated with metformin and is a diagnosis of exclusion. It should be considered during the perioperative period if there is suspicion of metformin accumulation. It is associated with a high mortality rate; hence, prompt recognition. | ||||
| Keywords | ||||
| Metformin; lactic acidosis; Diabetes mellitus; Coronary Artery Bypass Graft | ||||
|
Statistics Article View: 73 PDF Download: 51 |
||||
